Maulasri Bhatta
0000-0001-8824-8884
Publication & Citation Trends
Publications
0 total
Abstract 350: AUTX-703, a novel and potent KAT2A and KAT2B protein degrader, induces differentiation and provides a potential therapeutic opportunity in subtypes of prostate cancer
Cited by 0
Semantic Scholar
Abstract 903: AURIGIN: A comprehensive single-cell OMICs atlas of human development and an AI/ML framework to classify and identify the drivers of tumor plasticity and altered cellular state
Cited by 0
Semantic Scholar
AUTX703, a Novel and Potent KAT2A and KAT2B Protein Degrader, Induces Differentiation and Offers Survival Advantage in a Primary Human AML Xenograft Model
Cited by 2
Semantic Scholar
Abstract 5795: Potent and selective degradation of KAT2A and KAT2B induces profound cell state changes and inhibits growth of AML, SCLC and NEPC model systems
Cited by 1
Semantic Scholar
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. OA
Cited by 271
Semantic Scholar
Abstract 2119: KRAS and fungi cooperate to drive IL33 secretion and type 2 immunity in the pancreatic cancer tumor microenvironment
Cited by 0
Semantic Scholar
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments OA
Cited by 33
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(3)
Retinal Diseases and Treatments
(3)
Immunotherapy and Immune Responses
(3)
Cancer, Hypoxia, and Metabolism
(3)
Extracellular vesicles in disease
(3)
Affiliations
Roswell Park Comprehensive Cancer Center
State University of New York
Exicure (United States)
Immune Modulatory Therapies (United States)
Io Therapeutics (United States)